Suppr超能文献

[Medical prescription of cannabis-the legal situation becomes clarified].

作者信息

Tolmein Oliver

机构信息

Zentrum für Medizinrecht, Georg-August-Universität Göttingen, Göttingen, Deutschland.

Kanzlei Menschen und Rechte, Kühnehöfe 20, 22761, Hamburg, Deutschland.

出版信息

Schmerz. 2019 Oct;33(5):443-448. doi: 10.1007/s00482-019-00410-7.

Abstract

BACKGROUND

Since March 2017 the law amending narcotics and other legal regulations has made it possible for doctors to prescribe cannabis and cannabis-derived medicines. The introduction of § 31 para 6 of the Social Code Book V (SGB V) allows that patients can be treated with cannabis-derived medicines at the expense of the statutory health insurance if they have a severe illness.

COURT DECISIONS

The law requires the approval of a prescription of cannabis for medical purposes by the health insurance before the granting of benefits. Due to denied permission, numerous cases are pending before the social tribunals. The article presents which legal issues are decided and why there is still no case law from the Federal Social Court on the essential questions.

OUTLOOK

The possibility of prescribing cannabis as medicine at the expense of the health insurance is an important advance in social law. The § 31 para 6 SGB V should be evaluated as soon as possible. The provisions of SGB V for the reimbursement of off-label treatment should be harmonized with § 31 para 6 SGB V.

摘要

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验